clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with clarithromycin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ruiz-González A et al. | Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. | 2007 | Respirology | pmid:17207036 |
Ding FM et al. | Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection. | 2012 | Respirology | pmid:22404374 |
Strouvalis I et al. | Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence. | 2018 | Respirology | pmid:29741298 |
Sawabuchi T et al. | Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza. | 2009 | Respirology | pmid:19909463 |
Okimoto N et al. | Clinical features of Q fever pneumonia. | 2004 | Respirology | pmid:15182283 |
Kikuchi E et al. | Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid. | 2008 | Respirology | pmid:18339019 |
Isozumi R et al. | Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae. | 2009 | Respirology | pmid:19732389 |
Liapakis IE et al. | Penetration of clarithromycin in experimental pleural empyema model fluid. | 2005 May-Jun | Respiration | pmid:15942299 |
Rovira E et al. | Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime. | 1999 | Respiration | pmid:10516537 |
Huchon G | How to manage the low-risk patient with lower respiratory tract infection? | 1999 | Respiration | pmid:10577170 |
Kobashi Y and Matsushima T | The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study. | 2007 | Respiration | pmid:16954651 |
Jouneau S et al. | Clarithromycin stops lung function decline in airway-centered interstitial fibrosis. | 2013 | Respiration | pmid:23095475 |
Fujiuchi S et al. | Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease. | 2003 Jan-Feb | Respiration | pmid:12584395 |
Persson CG and Uller L | Resolution of cell-mediated airways diseases. | 2010 | Respir. Res. | pmid:20540713 |
Ballard HO et al. | Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. | 2007 | Respir. Res. | pmid:17550598 |
Amado-RodrÃguez L et al. | Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury. | 2013 | Respir. Res. | pmid:23663489 |
Beigelman A et al. | Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis. | 2010 | Respir. Res. | pmid:20591166 |
du Toit LC et al. | Tuberculosis chemotherapy: current drug delivery approaches. | 2006 | Respir. Res. | pmid:16984627 |
Komiya K et al. | Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts. | 2017 | Respir. Res. | pmid:28219384 |
Legssyer R et al. | Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. | 2006 | Respir. Res. | pmid:17064416 |
Kadota J et al. | Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. | 2003 | Respir Med | pmid:12854636 |
Miravitlles M et al. | Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. | 2005 | Respir Med | pmid:15950136 |
Lode H et al. | Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia. | 2003 | Respir Med | pmid:14561021 |
Niederman MS et al. | Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents. | 2006 | Respir Med | pmid:16531032 |
Hoeffken G et al. | The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia. | 2001 | Respir Med | pmid:11453311 |
Hagberg L et al. | Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis. | 2003 | Respir Med | pmid:12814146 |
Kohyama T et al. | Clarithromycin inhibits fibroblast migration. | 2008 | Respir Med | pmid:18701271 |
Abe M et al. | A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D4/E4 receptor antagonist. | 1998 | Respir Med | pmid:9893782 |
Kobashi Y et al. | A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. | 2007 | Respir Med | pmid:16750618 |
Simoens S et al. | Preventing COPD exacerbations with macrolides: a review and budget impact analysis. | 2013 | Respir Med | pmid:23352223 |
Banerjee D et al. | The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD. | 2005 | Respir Med | pmid:15715188 |
Carbon C et al. | Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia. | 2006 | Respir Med | pmid:16376537 |
Yatera K et al. | The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases. | 2017 | Respir Investig | pmid:29153420 |
Higashi F et al. | Additional treatment with clarithromycin reduces fever duration in patients with influenza. | 2014 | Respir Investig | pmid:25169846 |
Suzuki K et al. | Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance. | 2018 | Respir Investig | pmid:29325687 |
Heifets LB | Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy. | 1994 Mar-Apr | Res. Microbiol. | pmid:7809471 |
Dautzenberg B | Clinical trials in Mycobacterium avium therapy: lessons to take home. | 1994 Mar-Apr | Res. Microbiol. | pmid:7809472 |
Horgen L et al. | Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium. | 1997 | Res. Microbiol. | pmid:9765852 |
Yajko DM | In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? | 1992 | Res. Microbiol. | pmid:1455069 |
Sander P et al. | Ribosomal drug resistance in mycobacteria. | 1996 Jan-Feb | Res. Microbiol. | pmid:8761724 |
Kargar M et al. | Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal disorders. | 2012 | Res. Microbiol. | pmid:22177975 |
Komori T et al. | Effect of clarithromycin on alpha1-acid glycoprotein levels in normal and diabetic rats. | 1998 | Res. Commun. Mol. Pathol. Pharmacol. | pmid:9874281 |
Ives TJ et al. | Disposition and functions of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions. | 2001 | Res. Commun. Mol. Pathol. Pharmacol. | pmid:12760488 |
Yatsunami J et al. | Clarithromycin is a potent inhibitor of tumor-induced angiogenesis. | 1997 | Res Exp Med (Berl) | pmid:9440137 |
Sharma H et al. | Fortuitous vasculitis. | 2012 | Ren Fail | pmid:22250755 |
Wen YK and Chen ML | Crescentic glomerulonephritis associated with non-tuberculous mycobacteria infection. | 2008 | Ren Fail | pmid:18350456 |
Itatsu T et al. | Eradication of Helicobacter pylori in hemodialysis patients. | 2007 | Ren Fail | pmid:17365917 |
Parola D et al. | [Efficacy and safety of clarithromycin in the treatment of community-acquired pneumonia]. | 2000 | Recenti Prog Med | pmid:10705778 |
Vaira D et al. | [Treatment for Helicobacter pylori: current criteria]. | 2007 | Recenti Prog Med | pmid:18044409 |
Palumbo E et al. | [Mycoplasma pneumoniae encephalitis in immunocompetent child]. | 2008 | Recenti Prog Med | pmid:18710062 |
Zautner AE | Adenotonsillar disease. | 2012 | Recent Pat Inflamm Allergy Drug Discov | pmid:22452646 |
Bergamaschi A et al. | Recent Advances in the Treatment of Helicobacter pylori Infection. | 2007 | Recent Pat Antiinfect Drug Discov | pmid:18221177 |
Campo SM et al. | Antibiotic treatment strategies for Helicobacter pylori infection. | 2007 | Recent Pat Antiinfect Drug Discov | pmid:18221161 |
Leonard S et al. | Application of liquid chromatography/ion trap mass spectrometry to the characterization of the related substances of clarithromycin. | 2006 | Rapid Commun. Mass Spectrom. | pmid:16991103 |
Calza P et al. | Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass spectrometry. | 2012 | Rapid Commun. Mass Spectrom. | pmid:22730089 |
Kim HS et al. | Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. | 2012 | Radiology | pmid:22371609 |
Ozdemir A et al. | Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis. | 2001 | Quintessence Int | pmid:12066673 |
Lin YH and Liu TC | Mycobacterium chelonae infection involving the auricle. | 2012 | QJM | pmid:21908384 |
Browne G et al. | A potential role for keratinocyte growth factor and clarithromycin in the treatment of paraquat overdose. | 2010 | QJM | pmid:20154068 |
Harvey E and Varatharaj A | Round pneumonia. | 2014 | QJM | pmid:23708793 |
Lin CM et al. | Is ionizing radiation a risk factor to diffuse panbronchiolitis? | 2017 | QJM | pmid:28069906 |
Burch LH and Picher M | E-NTPDases in human airways: Regulation and relevance for chronic lung diseases. | 2006 | Purinergic Signal. | pmid:18404479 |
Hasegawa N et al. | Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease. | 2009 | Pulm Pharmacol Ther | pmid:19061965 |
Yamada K et al. | Azithromycin inhibits MUC5AC induction via multidrug-resistant Acinetobacter baumannii in human airway epithelial cells. | 2014 | Pulm Pharmacol Ther | pmid:24910464 |
Morinaga Y et al. | Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. | 2009 | Pulm Pharmacol Ther | pmid:19716898 |
Gao X et al. | Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. | 2010 | Pulm Pharmacol Ther | pmid:19895898 |
Liu CP et al. | NO-releasing xanthine KMUP-1 bonded by simvastatin attenuates bleomycin-induced lung inflammation and delayed fibrosis. | 2014 | Pulm Pharmacol Ther | pmid:23518214 |
Nakamura M et al. | Clarithromycin ameliorates pulmonary inflammation induced by short term cigarette smoke exposure in mice. | 2015 | Pulm Pharmacol Ther | pmid:26363279 |
Martynova AV et al. | Emergence of Haemophilus influenzae Strains in the Nasopharynx of Children with Tuberculosis. | 2011 | Pulm Med | pmid:21766017 |
Rafii R et al. | Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease. | 2011 | Pulm Med | pmid:21660228 |
Figueiredo Bde C and Ibiapina Cda C | The role of macrolides in noncystic fibrosis bronchiectasis. | 2011 | Pulm Med | pmid:22292118 |
Warner A | Clarithromycin--a precipitant for acute psychotic stress. | 2000 Nov-Dec | Psychosomatics | pmid:11110120 |
Mermelstein HT | Clarithromycin-induced delirium in a general hospital. | 1998 Nov-Dec | Psychosomatics | pmid:9819955 |
Jiang F et al. | The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes. | 2015 | Psychopharmacology (Berl.) | pmid:25510856 |
Härtig G et al. | [Symptomatic psychosis in bland sinus thrombosis and antibiotic therapy]. | 1999 | Psychiatr Prax | pmid:10457975 |
Mrozińska M | [Legionellosis in three children--cases report]. | 2005 | Przegl Epidemiol | pmid:16729426 |
Mach T and Zahradnik-Bilska J | [Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication]. | 1999 | Prz. Lek. | pmid:10575912 |
Hydzik P et al. | [Drug-induced erythrodermia complicated by multiorgan failure--case report]. | 2011 | Prz. Lek. | pmid:22010450 |
Trzebiatowska I et al. | [Psychosis caused by the treatment with clarithromycin--a case report]. | 2011 | Prz. Lek. | pmid:22010468 |
Zwolińska-Wcisło M and Palka M | [Principles of managing Helicobacter pylori infections. Guidelines of the European Society of Gastroenterology in Primary Health Care]. | 2000 | Prz. Lek. | pmid:11293204 |
Thorley JA et al. | Mechanisms of viral entry: sneaking in the front door. | 2010 | Protoplasma | pmid:20446005 |
Sato Y et al. | Macrolide antibiotics promote the LPS-induced upregulation of prostaglandin E receptor EP2 and thus attenuate macrolide suppression of IL-6 production. | 2007 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:17324565 |
Miyazaki M et al. | Macrolide antibiotics inhibit prostaglandin E2 synthesis and mRNA expression of prostaglandin synthetic enzymes in human leukocytes. | 2003 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12907132 |
Björkholm B et al. | Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11717398 |
Pfister P et al. | 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-->G. | 2005 | Proc. Natl. Acad. Sci. U.S.A. | pmid:15795375 |
Fahey JW et al. | Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. | 2002 | Proc. Natl. Acad. Sci. U.S.A. | pmid:12032331 |
Shmelev EI et al. | [Clarythromycin in the treatment of exacerbations of chronic obstructive lung disease]. | 2006 | Probl Tuberk Bolezn Legk | pmid:17002058 |
James GD et al. | Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study. | 2013 | Prim Care Respir J | pmid:23839240 |
Kwan BY and Rabheru K | Manic episode associated with clarithromycin in a patient with medically treated depression. | 2012 | Prim Care Companion CNS Disord | pmid:22943025 |
Sellal A et al. | [Maintenance treatment of cerebral toxoplasmosis in AIDS: role of clarithromycin-minocycline combination]. | 1996 | Presse Med | pmid:8685115 |
Contios S et al. | [Mycobacterium marinum tenosynovitis of the abductors]. | 2005 | Presse Med | pmid:15962499 |
Saint-Marc T et al. | [Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases]. | 1993 | Presse Med | pmid:8121903 |
Guillemet C et al. | [Clarithromycin-digoxin: an unrecognized interaction in some patients]. | 1997 | Presse Med | pmid:9137381 |
Esvant H et al. | [Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. | 1993 | Presse Med | pmid:8337221 |
de Masson A et al. | Cavitary pulmonary disease in a patient treated with natalizumab. | 2014 | Presse Med | pmid:24742610 |
Mégraud F | [Helicobacter pylori: bacteriological aspects, diagnostic methods, and susceptibility to antibiotics]. | 2008 | Presse Med | pmid:18261874 |
Songné B et al. | [Buruli ulcer in Togo: 21 cases]. | 2001 | Presse Med | pmid:11317927 |
Courillon-Mallet A | [Treatment of Helicobacter pylori infection]. | 2008 | Presse Med | pmid:18255253 |
Morlet-Barla N et al. | [Severe hypoglycemia and recurrence caused by disopyramide-clarithromycin interaction]. | 2000 Jul 8-15 | Presse Med | pmid:10938688 |
Olivier D | [HIV: a guide on management of seropositive patients]. | 2001 | Presse Med | pmid:11268903 |